COVID-19 Update: How to Stay Safe from the Emerging Nimbus Strain
The new Omicron sub-variant, Nimbus (NB.1.8.1), has now become the dominant strain in the United States
Omicron: What are the Symptoms of the New Covid Variant
- Tweet
Send to Kindle
Pixabay
Fatigue is one of the main symptoms of the new variant of the coronavirus - Omicron. This is explained by the President of the South African Medical Association Angelique Coetzee, writes Sky News.
According to her, patients who tested positive for the new COVID variant complained of throat irritation, mild headaches and body aches. So far, those infected have not reported a loss of sense of smell. There is no decrease in oxygen levels in the blood.
Cases of the infection in South Africa, where this variant of COVID-19 was first discovered, are not serious, Coatzee told the BBC. She expressed concern about older people who have comorbidities such as heart problems or diabetes.
Omicron's symptoms are unusual, but not severe, says the doctor, who was the first to report the possibility of a new variant, BTA writes.
/Nova
Related Articles:
FLiRT Variant of Omicron Detected in Bulgaria: Preliminary Cases Confirmed
Preliminary reports indicate that strains of the FLiRT variant of "Omicron" have been detected in Bulgaria
Bulgarian Court Clears 'Revival' Leader of COVID Panic Charges
Bulgaria's Sofia District Court has rendered a verdict, declaring Kostadin Kostadinov innocent of charges related to inciting fear and panic
Politics | April 8, 2024, Monday // 13:29
Plovdiv's Tourism Industry Bounces Back, Exceeding Pre-Pandemic Figures
Plovdiv's tourism sector is steadily approaching a complete rebound, showcasing a return to pre-pandemic levels, as revealed by the latest data from the National Statistics for the initial nine months of this year.
Restoring Sense of Smell: Breakthrough Treatment for Long-Term COVID Effects
Long-term effects of COVID-19 continue to challenge individuals, particularly those dealing with the persistent loss of smell
COVID Vaccine sales collapse as Pfizer cuts costs
Pharmaceutical giant Pfizer said it plans a cost-cutting operation if its co-developed with BioTech COVID-19 vaccine and antiviral treatment for the coronavirus continue to underperform in the coming months due to falling demand
Flu and Respiratory Illness Rates in Bulgaria Remain Lower Than Last Year
Flu and acute respiratory disease rates in Bulgaria remain lower than those recorded at the same time last year
Flu Season Still Quiet in Bulgaria, Vaccination Urged Before January Peak
In Bulgaria, there have been no confirmed cases of influenza over the past week
Fentanyl Deaths in Bulgaria Soar Tenfold in Just One Year, Experts Warn of Hidden Crisis
Bulgaria has witnessed a dramatic surge in deaths linked to opioids, predominantly fentanyl
COVID-19 Cases Climb in Bulgaria as Vaccine Demand Soars Ahead of Winter
With the arrival of autumn, respiratory illnesses are once again on the rise across Bulgaria, with doctors noting a noticeable increase in COVID-19 infections
Bulgaria’s Flu Season to Peak in Late January, COVID-19 Still Dominates Respiratory Illnesses
Prof. Iva Hristova, director of the National Center for Infectious and Parasitic Diseases, has forecast that Bulgaria is likely to see the peak of the flu season in the last week of January
The Hidden Health Effects of the October Time Change
Every October, as clocks are turned back one hour, many people welcome what they see as an “extra hour of sleep.”
